Lexology November 9, 2021
Baker McKenzie

Last month, medical device regulators in the US, Canada and the UK issued 10 key guiding principles to facilitate the development of effective, safe and high quality artificial intelligence/machine learning (AI/ML) enabled medical devices. The project involves the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) in collaboration with the US Food and Drug Administration (FDA) and Health Canada (the Regulators).

We’ve set out our top 5 takeaways from the guidance below.

1. Aims to ensure that the medical devices produced are effective, safe and of high-quality: Developments in AI/ML have shown potential to radically expand and transform this sector. However, the complexities in this field (as well as the pace of innovation) necessitate a strong message of Good Machine...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), FDA, Govt Agencies, Medical Devices, Technology
‘Think about the hype’ - AI holds disruptive potential for health care
Will Synthetic, AI-Based Digital Humans Change Pharma and Life Sciences? Q&A with Abid Rahman, SVP Innovation, EVERSANA
Investigators Train AI Systems to Predict RA Outcomes
Confronting the Digital Dilemma in Healthcare’s Quest for Innovation
NIH develops AI tool to better pair cancer patients with drugs

Share This Article